DC CFAR Presenters and Award Recipients at the Conference for Retroviruses & Opportunistic Infections (CROI) 2024 | |
|
The DC CFAR is proud to announce the investigators from DC CFAR institutions who will be presenting their research and receiving awards at this year's Conference on Retroviruses & Opportunistic Infections (CROI) happening from March 3-6 in Denver, Colorado.
This includes investigators from Howard University (HU), George Washington University (GW), Georgetown University (GU), and Whitman Walker (WW). Please see the following presenters and awardees below:
- Mikaley Bolden (GU)
- Presentation Title: "HIV Clinical Factors and Cardiovascular Disease Risk Predict White Matter Hyperintensity Burden" – Poster Presentation
- Recipient of "Young Investigator" Award
- David Fessler (with Jonathon Rendina) (WW)
- Presentation Title: "Implementing Long-Acting ART in a Community Health Center: Insights and Early Outcomes" – Poster Presentation
- Presented During: Long-Acting Antiretroviral Therapy and PrEP - Session-U08
- Matilde Jacobson (GW)
- Presentation Title: "Vaginal Immune Dysregulation in Transgender/Non-Binary Individuals on Masculinizing Hormone Therapy" – Poster Presentation
- Presented During: New Directions in Sexual and Reproductive Health and HIV Prevention - Session-T5
- Ezer Kang (HU)
- Presentation Title: "Social Determinants of Health of Adolescents and Youth with Perinatally Acquired HIV" – Panel Presentation
- Presented During: Living into Young Adulthood with Perinatal HIV Panel
- Lili (Xinyi) Li (GW)
- Presentation Title: "HIV Prevention Service Use Among PWID in Washington, DC, Pre- and Post-COVID Pandemic Eras" – Poster Presentation
- Presented During: "Hazards Ahead: The Intersection of HIV and Substance Use"
- Recipient of "New Investigator Scholarship" Award
- Elyse McMahon (GW)
- Presentation Title: "Retinoids Enhance NK Natural and Antibody-Dependent Cell Cytotoxicity of HIV-Infected CD4 T" – Poster Presentation
- Recipient of "Young Investigator" Award
- Teresa Murphy (GW)
- Presentation Title: "Studying Dual Role of Glycosylation in Resistance to Broadly Neutralizing Antibodies In Vitro" – Poster Presentation
- Presented During: Broadly Neutralizing Antibodies and Resistance - Session-H3
- Lauren O’Connor (GW)
- Presentation Title: "Application of STOPP Criteria in an Urban Cohort of People Aging With HIV" – Poster Presentation
- Presented During: Aging and Frailty - Session-L9
- Recipient of "Young Investigator" Award
- Michelle Premazzi Papa (GW)
- Presentation Title: "Naive B Cells from Unvaccinated Rhesus Macaques Cross-React with HIV gp140 Protein" – Poster Presentation
- Presented During: HIV Vaccines - Session-C2
- Recipient of "New Investigator Scholarship" Award
- Rachel Scott* (GU)
- Presentation Title: "Arteriolar Dysfunction in Placentas of HIV-Exposed, Small-for-Gestational-Age Neonates" – Poster Session
- Presented During: HIV and Birth Outcomes - Session-O6
- Peyton Thomas (GU)
- Presentation Title: "HIV Status and APOE4 Differentially Impact White Matter Integrity in Adults With HIV” – Poster presentation
Please join us in congratulating our DC CFAR investigators and awardees, and we encourage those attending CROI 2024 to attend their respective presentations/sessions. For more information on CROI 2024, visit their website here.
| |
DC CFAR Developmental Core "My Path to Independence in HIV Research" Featuring Dr. Anthony Fauci, Thurs, March 21, from 4:00-5:00PM ET | |
Please join us for the DC CFAR Developmental Core Lecture Series: My Path to Independence in HIV Research. Each hour-long session in this series will showcase prominent researchers from across the country and autobiographical accounts of their careers in HIV research, specifically their pathways to career and research independence.
Our next lecture will feature Dr. Anthony Fauci, Distinguished University Professor in the Division of Infectious Diseases at Georgetown University School of Medicine and former Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH). Dr. Fauci will discuss his perspectives on pursuing a research career in HIV-related science. We plan to follow his 30-minute presentation with a 30-minute Q&A session. We kindly ask that participants submit questions for Dr. Fauci in advance in the registration form linked below. Questions can be submitted in the chat box during the session as well.
Register for the seminar here.
| |
DC CFAR Developmental Core Benchside to Community Seminar, Thurs, Feb 29, 2024, from 12:00-1:00 PM EST | |
Please join us for the DC CFAR Developmental Core Benchside to Community Virtual Seminar on
“Genetic cures for HIV: the CRISPR/Cas9 system” on Thursday, February 29, from 12:00-1:00PM ET. The goal of this seminar is to:
- Build a conversation between researchers and community members on their perspectives of HIV cure research.
- Showcase underrepresented people in the field and share their stories and motivations behind their research.
- Foster collaboration, discussion, and public awareness on HIV cure research.
The seminar will include a presentation by DC CFAR investigator, Dr. Lee Campbell (left) followed by a Q&A and discussion with DC CFAR Community Partnership Council (CPC) member, Mr. Kenya Hutton (middle), and CFAR Diversity, Equity, and Inclusion Pathway Initiative (CDEIPI) Scholar, Ms. Morgan Scott (right).
Register Here!
| | |
DC CFAR Women and HIV SIG and SGM SIG Virtual Seminar in recognition of National Women and Girls HIV/AIDS Awareness Day, Fri, March 8, 11-12PM ET | |
Please join the Women and HIV Scientific Interest Group (SIG) and Sexual and Gender Minorities (SGM) SIG for a virtual on Friday, March 8, from 11:00-12:00 pm ET. In recognition of National Women and Girls HIV/AIDS Awareness Day on March 10, the seminar will focus on HIV prevention for transgender women.
The event will feature presentations from DC CFAR member, Dr. Ana María del Río-González (left) and Women and HIV SIG Academic Co-Lead, Dr. Mimi Ghosh (right). The presentations will be followed by a panel discussion with community partners. Additional information on the agenda is forthcoming. Please register for the event at the link below.
Register Now!
| |
DC CFAR Investigator Dr. Rachel Scott's Study Added to CDC Compendium | |
DC CFAR Investigator, Dr. Rachel Scott's (Georgetown) study entitled "HIV PrEP Services for Urban Women" was added to the CDC's Compendium of Evidence-Based Interventions and Best Practices for HIV Prevention, under PrEP Services, linked here.
The study that these recommendations draw from are from Dr. Scott's study entitled, "Implementation of an Educational Intervention to Improve HIV Pre-Exposure Prophylaxis Services for Women in an Urban Sexual Health Clinic," which can be read online in the Journal of AIDS Patient Care and STDs.
| | |
DC CFAR Investigator, Dr. Sarah Calabrese, Publishes Two New Articles | |
DC CFAR Investigator, Dr. Sarah Calabrese (GWU) has recently published two new articles. The first article is entitled, "The Potential Role of Undetectable = Untransmittable (U = U) in Reducing HIV Stigma among Sexual Minority Men in the US," and the second article is entitled "The Implications of PrEP Use, Condom Use, and Partner Viral Load Status for Openness to Serodifferent Partnering Among US Sexual Minority Men," both published in the Journal of AIDS and Behavior. These were published in collaboration with other GW investigators, national and international university partners, and CBOs. Please use the above links to read more.
| |
DC CFAR Investigator, Dr. Lee Campbell Publishes New Article | |
DC CFAR Investigator, Dr. Lee Campbell (Georgetown) recently publsihed a new paper entitled, "Gesicles packaging dCas9-VPR ribonucleoprotein complexes can combine with vorinostat and promote HIV proviral transcription," in the Journal of Molecular Therapy Methods & Clinical Development, with colleagues at the Laboratory of Preclinical Neurobiology, Department of Neuroscience at Georgetown University. This paper found that a combination of dCas9-VPR gesicles with other latency-reversing agents may provide a complementary method to activate latent HIV in future studies utilizing patient-derived cells or small animal models. Use the link here to read the full article.
| | |
Do you have an event you would like to see included in the next edition of the Community Spotlight? We invite any news or updates from the DC CFAR community and encourage you to send information that may be of interest to CFARinDC@gmail.com. | |
|
CROI: Conference on Retroviruses and Opportunistic Infections 2024 (Abstract Submission here)
March 3-6, 2024
Denver, CO
Inter-CFAR Substance Use Research Community (I-SURC) Networking Meeting (During CROI) - Are you attending CROI and interested networking with other substance use researchers? Register now!
March 3, 2024
Denver, CO
Save the Date – National 2024 Ryan White Conference on HIV & Treatment (AIDSWatch)
March 17-19, 2024
Washington, DC
Save the Date: MACC School of Nursing (SON) Conference
May 2-3, 2024
Baltimore, MD
ACTHIV 2024: Registration Open
May 2-4, 2024
Atlanta, GA | Hybrid
SYNC 2024: Registration Now Open & Call for Abstracts
May 29-31, 2024
Washington, DC
19th International Conference on HIV Treatment & Prevention Adherence – Continuum 2024
June 9-11, 2024
Puerto Rico
IAS 2024
July 22-26
Munich, Germany
National LGBTQ+ Health Conference
August 15-17, 2024
Atlanta, GA
2024 National Ryan White Conference on HIV Care & Treatment
August 20-23, 2024
US Conference on HIV/AIDS (USCHA) 2024: Registration Open
September 12-15, 2024
New Orleans, LA
HIVR4P 2024, the 5th HIV Research for Prevention Conference (Registration Now Open and Application for Scholarships Available!)
October 6-10, 2024
Lima, Peru | Hybrid
For more DC CFAR events please see the calendar here.
| |
FUNDING, TRAINING, & MENTORING OPPORTUNITIES & SEMINARS | |
|
Harvard CFAR Annual Scientific Symposium & Poster Session - "Immunodysregulation in Human Diseases"- March 1, 2024 Event time 8:00 am - 4:30 pm
Nationally recognized experts will discuss the roles of immunoregulation in human diseases. Short talks will additionally be selected from submitted abstracts. Our goal is to coalesce discussions of immune dysfunction in pathogenesis and treatment of HIV infection. Register here.
HIV and Drug Abuse Prevention Research Ethics Training Institute (RETI) Fellowship, Up to $30,000, Applications Due March 1st.
The Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute (RETI), awards $30,000 to accepted early career investigators to conduct an institute-funded research project on ethical issues in HIV and drug use research. For more information and eligibility, use the link here.
NEW - Using Health Informatics to Identify & Link People with Opioid Use Disorder to Clinical Care and Research Initiatives (UAB CFAR) - Thursday, March 7, 2024 at 2:00 PM ET (VIRTUAL ONLY)
Presented by the University at Alabama at Birmingham CFAR - Substance Use SWG. Register here.
Modelers and Storytellers: Transdisciplinary Training to Advance Community Health Intervention Research, Priority Deadline due March 11th
The Modelers and Storytellers Transdisciplinary Training is a two-week virtual summer research education program that will prepare predoctoral and postdoctoral trainees as well as early-career researchers to apply systems and/or data science methods to community-engaged health disparities research. The goal is to accelerate the translation of research into practice to address real-world, complex health issues especially as they relate to health disparities. Use the link here for more information and to apply.
Seeking Input on the Next NIH Strategic Plan for HIV and HIV-Related Research; RFI due by March 28, 2024
"The NIH Office of AIDS Research (OAR) has issued a Request for Information (RFI) as one source of input to inform development of the FY 2026‒2030 NIH Strategic Plan for HIV and HIV-Related Research. Feedback from all interested constituents—including, but not limited to, researchers, health care professionals, advocates and health advocacy organizations, scientific or professional organizations, public health officials, government agencies, and community members—is a critical part of this process." More information available here.
NEW - Northwestern’s NIBIB-funded Center for Innovation in Point of Care Technologies for HIV and Emerging Infectious Diseases (C-THAN); Expression of Interest Due March 31st, 2024
C-THAN is specifically seeking proposals focused on increasing patient access to HIV viral load monitoring which may include the development of novel viral load diagnostics, technology that enables sample collection and/or plasma separation, field testing of assays in development, or implementation studies of current or near commercial tests. For more information and to apply, click here.
CDRF: 2024 CFAR HIV/AIDS Training Fellowship Awards, Seeking Indian National Applicant - Intent to Apply due by March 31st, 2024
CRDF Global is now accepting proposals from Centers for AIDS Research (CFARs) to support early-stage investigators from India working in the field of HIV/AIDS research for the 2024 CFAR HIV/AIDS Training Fellowship Awards. This two-year fellowship program aims to promote the training and inclusion of early-stage Indian scientists in HIV-related collaborative research within the CFAR program. Applications should come from CFARs and identify at least one Indian fellowship candidate. The initial intent to apply deadline is March 31, 2024; applications are due by July 31, 2024. For questions, please contact Annie King (aking@crdfglobal.org).
Workshop for Early Career Investigators in HIV, April 24, 2024, 11AM–4PM ET
The National Institutes of Health (NIH) Office of AIDS Research (OAR), along with the NIH institutes, centers, and offices (ICOs) with HIV research programs invite you to attend the Workshop for Early Career Investigators in HIV on Wednesday, April 24, 2024. OAR looks forward to building on the enthusiasm and feedback from the first two early career investigator (ECI) workshops in 2022 and 2023. OAR’s goal is to continue to provide knowledge, resources, and mentoring to the next generation of HIV investigators. Register here.
NEW - Post-Doctoral (T32) Training Program in Ending the HIV Epidemic – Application Open at Emory University - Full applications are due May 3, 2024.
Emory Training Program in Translational Research to End the HIV Epidemic is now accepting applications to fill postdoctoral slots for January and July 2024. Interested and eligible candidates must complete an online interest form on or before April 12, 2024 to be connected to one of the Program Directors, Drs. Ann Chahroudi, Colleen Kelley, or Patrick Sullivan, to discuss their application. The program will offer a continuous rolling application and deadlines will vary depending on the intended start date. More information here.
| |
NIH FUNDING OPPORTUNITIES
| |
|
HIV Cure-Related Research in Diverse Populations
Funding Opportunity Number: NOT-AI-23-046
Posting Date: June 23, 2023
Opening Date: September 07, 2023
Close Date: May 08, 2026
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-225
Posting Date: June 27, 2023
Opening Date: August 07, 2023
Close Date: Various – See announcement
Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DK-25-001
Posting Date: November 30, 2023
Opening Date: February 20, 2024
Close Date: Various – See announcement
Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity Number: RFA-AI-23-060
Posting Date: October 25, 2023
Opening Date: February 13, 2024
Close Date: March 14, 2024
Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
Funding Opportunity Number: PAR-23-112
Posting Date: January 31, 2023
Opening Date: February 24, 2023
Close Date: Various – See announcement
Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-018
Posting Date: August 21, 2023
Opening Date: July 5, 2024
Close Date: August 2024
Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-001
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required)
Funding Opportunity Number: RFA-OD-23-018
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
| |
|
NEW - NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
Funding Opportunity Number: NOT-AI-23-046
Posting Date: June 3, 2023
Opening Date: September 13, 2023
Close Date: Various - See announcement
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-297
Posting Date: September 19, 2023
Opening Date: December 07, 2023
Close Date: Various – See announcement
Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-22-185
Posting Date: May 27, 2022
Opening Date: December 07, 2023
Close Date: Various – See announcement
NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-198
Posting Date: June 02, 2023
Opening Date: September 13, 2023
Close Date: Various – See announcement
Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
Funding Opportunity Number: PAR-23-061
Posting Date: January 11, 2023
Opening Date: April 09, 2023
Close Date: January 10, 2026
Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
Funding Opportunity Number: PAR-23-060
Posting Date: January 11, 2023
Opening Date: April 09, 2023
Close Date: January 10, 2026
Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
Funding Opportunity Number: NOT-MH-23-275
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
Notice of Special Interest (NOSI): Research on HIV-associated Malignancies
Funding Opportunity Number: NOT-CA-23-070
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
| |
Click here for additional funding opportunities available from the National Institutes of Health. | |
The DC CFAR is an NIH funded program (P30AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NINR, NIMHD, FIC, and OAR. The content isthe responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. | | |
| | | |
